subscribe
 

Pharma firm invests in LIMS

9th July 2019


Pharmaceutical company Hemofarm, based in Vršac, Serbia, has started a project with the Matrix Gemini Stability Management System from Autoscribe Informatics. Hemofarm is a member of STADA Group, one of the largest generic pharmaceutical companies in the world. The Matrix Gemini Stability Management System will be for stability studies across Hemofarm's range of prescription drugs (Rx), over-the-counter medicines (OTC) and consumer healthcare products (CHC products).

Based on the Matrix Gemini Laboratory Management System, Matrix Gemini Stability helps to simplify the whole stability study management process, which can be complex and time consuming for multiple studies. The in-built stability study management functionality is designed to automate and control the entire operation of the stability study including: protocol creation, study initiation and management, inventory management, sample pull points, future workload reporting and stability study reporting. The system can produce shelf life projections and is also optionally capable of producing projected shelf life trend analysis.

John Boother, President of Autoscribe Informatics said, "We are pleased to be working with Hemofarm in their Stability Studies project. As one of the most complete and mature study management systems on the market today, Matrix Gemini Stability continues to gain traction and market share across the pharmaceutical industry. Its highly flexible graphical configuration tools ensure that the system can be configured to each customer's exact needs, while providing the flexibility for change as the customer's requirements evolve over time."





Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe